dr. kremyanskaya on manifest trial with cpi-0610 in myelofibrosis
Published 4 years ago • 55 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:08
dr. kremyanskaya on responses with cpi-0610 in patients with myelofibrosis
-
1:00
dr. kremyanskaya on effect of cpi-0610 in patients with myelofibrosis
-
1:02
dr. kremyanskaya on unmet needs in myelofibrosis
-
1:07
faces of the precision medicine initiative - dr. spero manson
-
1:38
dr. mascarenhas on the need to develop curative therapies in myelofibrosis
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
1:30
insights into the manifest-2 study
-
5:18
how can you learn more about myelofibrosis clinical trials?
-
2:21
update of manifest phase 2 study
-
1:21
an update on cartitude-2: cilta-cel in patients with multiple myeloma in second line
-
2:33
latest results from the cartitude-2 trial of cilta-cel in progressive multiple myeloma
-
1:34
car-t expansion is associated with treatment response, crs, and cytopenia in patients with r/r mm
-
14:48
2018 cholangiocarcinoma foundation annual conference #7 - day 1 - pcori
-
0:58
matthew ryba, p.a.-c.
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma
-
1:12:02
the genomic revolution and the future of medicine and health
-
1:19:50
deep medicine and the care revolution!
-
21:14
building on our current treatments – is precision medicine the future for cca?